18F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors. (Q53254259)

12 May 2018

title

18F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors. (English)

1 reference

12 May 2018

author name string

Kyoichi Kaira

1

1 reference

12 May 2018

Haruyasu Murakami

2

1 reference

12 May 2018

Satoru Miura

3

1 reference

12 May 2018

Rieko Kaira

4

1 reference

12 May 2018

Hiroaki Akamatsu

5

1 reference

12 May 2018

Madoka Kimura

6

1 reference

12 May 2018

Akira Ono

7

1 reference

12 May 2018

Asuka Tsuya

8

1 reference

12 May 2018

Yukiko Nakamura

9

1 reference

12 May 2018

Tateaki Naito

10

1 reference

12 May 2018

Toshiaki Takahashi

11

1 reference

12 May 2018

Masahiro Endo

12

1 reference

12 May 2018

Nobuyuki Yamamoto

13

1 reference

12 May 2018

publication date

21 December 2010

1 reference

12 May 2018

Annals of Nuclear Medicine

published in

1 reference

12 May 2018

volume

25

1 reference

12 May 2018

issue

4

1 reference

12 May 2018

page(s)

247-253

1 reference

12 May 2018

[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12149-010-0455-X

Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the Europ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-010-0455-X

Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-010-0455-X

Follow-up study of thymomas with special reference to their clinical stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-010-0455-X

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-010-0455-X

A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-010-0455-X

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-010-0455-X

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-010-0455-X

Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-010-0455-X

Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-010-0455-X

Value of 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-010-0455-X

Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-010-0455-X

Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-010-0455-X

Characterization of thymic masses using (18)F-FDG PET-CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-010-0455-X

10.1007/S12149-010-0455-X

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018